Generation of CD8+ T cells specific for transporter associated with antigen processing deficient cells

EZ Wolpert, M Petersson… - Proceedings of the …, 1997 - National Acad Sciences
EZ Wolpert, M Petersson, BJ Chambers, JK Sandberg, R Kiessling, HG Ljunggren, K Kärre
Proceedings of the National Academy of Sciences, 1997National Acad Sciences
Cells with impaired transporter associated with antigen processing (TAP) function express
low levels of cell surface major histocompatibility complex (MHC) class I molecules, and are
generally resistant to lysis by MHC class I restricted cytotoxic T lymphocytes (CTLs). Here we
report the generation of MHC class I restricted CD8+ CTLs that surprisingly require target
cell TAP deficiency for efficient recognition. C57BL/6 (B6) mice immunized with syngenic B7–
1 (CD80) expressing TAP-deficient cells generated a potent CTL response against both TAP …
Cells with impaired transporter associated with antigen processing (TAP) function express low levels of cell surface major histocompatibility complex (MHC) class I molecules, and are generally resistant to lysis by MHC class I restricted cytotoxic T lymphocytes (CTLs). Here we report the generation of MHC class I restricted CD8+ CTLs that surprisingly require target cell TAP deficiency for efficient recognition. C57BL/6 (B6) mice immunized with syngenic B7–1 (CD80) expressing TAP-deficient cells generated a potent CTL response against both TAP-deficient RMA-S tumor cells and TAP-deficient Con A blasts, whereas the corresponding TAP-expressing target cells were considerably less susceptible or resistant to lysis. The CTL epitopes recognized were expressed also by the human TAP-deficient cell line T2, transfected with appropriate MHC class I molecules. B6 mice immunized with B7–1-transfected TAP-deficient RMA-S cells were protected from outgrowth of a subsequent RMA-S tumor challenge. These findings are discussed in relation to the biochemical nature of MHC class I dependent CTL epitopes associated with impaired TAP function, as well as implications for immunotherapy and autoimmunity.
National Acad Sciences